On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines
Articolo
Data di Pubblicazione:
2018
Citazione:
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines / C. Scavone, C. Carnovale, R. Ruggiero, S. Radice, M. Scatigna, G. Racagni, A. Mugelli, F. Rossi, E. Clementi, A. Capuano. - In: CLINICAL THERAPEUTICS. - ISSN 0149-2918. - 40:11(2018 Nov), pp. 1931-1940. [10.1016/j.clinthera.2018.09.015]
Abstract:
This commentary outlines how discovery, development, and access to medicines are regulated and promoted in Italy by the government through the Ministry of University and Research, the Ministry of Health, and the Italian Medicines Agency. We describe and comment on the existing research programs stimulating preclinical, translational, and clinical research and how access to medicines and their pricing is regulated by Italy's National Health Service both at the national and regional levels. Finally, we describe the current scenario of industrial research and medicines manufacturing. The resulting picture shows a country in which high-level competitive research on medicines is promoted alongside an excellent national health system working toward fairness of access to health care services for all citizens and fiscal solidarity as a fundamental form of system financing. Critical challenges still exist, including the relative scarcity of public funding for research and the non-uniform access to the benefits of the National Health Service across Italian regions.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Italy; drug development
Elenco autori:
C. Scavone, C. Carnovale, R. Ruggiero, S. Radice, M. Scatigna, G. Racagni, A. Mugelli, F. Rossi, E. Clementi, A. Capuano
Link alla scheda completa: